Musculoskeletal Medicine in Rheumatic Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 26 March 2025 | Viewed by 52
Special Issue Editors
Interests: spondyloarthritis; crystal arthropathies; rheumatoid arthritis and sport related musculoskeletal involvement
Interests: ultrasound in rheumatic and musculo-skeletal diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Rheumatic diseases, including rheumatoid arthritis, axial and peripheral spondylarthritis, as well as crystal-related arthritis, are systemic inflammatory conditions that primarily affect the musculoskeletal system. These diseases cause chronic, often irreversible damage, leading to significant functional deficits and a reduced quality of life.
Recent advances in diagnostics, including early identification of immunological changes and modern imaging methods, such as musculoskeletal ultrasonography or magnetic resonance imaging, have revolutionized the management of these conditions. Over the past five decades, treatment goals have shifted from symptom relief to achieving and maintaining remission, stopping radiographic progression, and striving for drug-free remission.
New therapeutic agents, such as targeted synthetic disease-modifying antirheumatic drugs (tDMARDs) and biologics, are crucial in this evolution. Early diagnosis and identifying "hard-to-treat" cases, allowing for tailored treatment strategies, are essential for optimal outcomes.
This Special Issue provides comprehensive insights into the latest research, diagnostics, and therapies in musculoskeletal medicine for rheumatic diseases, serving as an essential resource for practitioners and researchers in the field.
Prof. Dr. Florentin Ananu Vreju
Prof. Dr. Emilio Filippucci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatic disease
- rheumatoid arthritis
- spondylarthritis
- microcrystal arthritis
- musculoskeletal ultrasonography
- biologic treatment
- disease-modifying antirheumatic drugs
- imagining techniques
